HealthLeaders Media June 21, 2018
Jack O'Brien

Gawande’s articles in The New Yorker lend some perspective to what he sees as the major drivers of high medical costs and how to address them.

Following the announcement by Amazon, Berkshire Hathaway, and JPMorgan Chase that Dr. Atul Gawande had been selected to serve as CEO of their joint healthcare enterprise, focus is now shifting to his plans on containing high medical costs.

Anyone looking for clues on how Gawande might approach his new job has plenty of material to pull from. His journalistic work has been impressing powerful business people and policymakers for years.

Related: Atul Gawande Named CEO of Amazon, Berkshire Hathaway, JPMorgan Healthcare Initiative

When the initiative was announced in January, Berkshire Hathaway CEO Warren...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Healthcare System, Insurance, Mergers & Acquisitions / JV, Self-insured, Trends
Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D Services Firm Evotec
How Joint Ventures Spark Innovation
Wellpath to sell behavioral division, declare bankruptcy: 5 notes
Inside the Balance That Makes These States Easier for Nursing Home Operators and Better for Dealmaking
CHS is gearing up to play offense again in hospital M&A game, CFO says

Share This Article